These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31585087)

  • 1. Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites.
    Lundby A; Franciosa G; Emdal KB; Refsgaard JC; Gnosa SP; Bekker-Jensen DB; Secher A; Maurya SR; Paul I; Mendez BL; Kelstrup CD; Francavilla C; Kveiborg M; Montoya G; Jensen LJ; Olsen JV
    Cell; 2019 Oct; 179(2):543-560.e26. PubMed ID: 31585087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics.
    Zhang X; Belkina N; Jacob HK; Maity T; Biswas R; Venugopalan A; Shaw PG; Kim MS; Chaerkady R; Pandey A; Guha U
    Proteomics; 2015 Jan; 15(2-3):340-55. PubMed ID: 25404012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomics.
    van der Mijn JC; Labots M; Piersma SR; Pham TV; Knol JC; Broxterman HJ; Verheul HM; Jiménez CR
    J Proteomics; 2015 Sep; 127(Pt B):259-63. PubMed ID: 25890253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-a by using functional proteomics technology.
    Ruan L; Wang GL; Chen Y; Yi H; Tang CE; Zhang PF; Li MY; Li C; Peng F; Li JL; Chen ZC; Xiao ZQ
    Med Oncol; 2010 Dec; 27(4):1407-14. PubMed ID: 20049563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular switches in signaling networks as a mechanism of action for oncogenic mutations in proximity of tyrosine residues.
    Emdal KB; Lundby A
    Mol Cell Oncol; 2020; 7(1):1692643. PubMed ID: 31993501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Phosphotyrosine Signaling Networks in Lung Cancer Cell Lines.
    Broncel M; Huang PH
    Methods Mol Biol; 2017; 1636():253-262. PubMed ID: 28730484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells.
    Chen Y; Low TY; Choong LY; Ray RS; Tan YL; Toy W; Lin Q; Ang BK; Wong CH; Lim S; Li B; Hew CL; Sze NS; Druker BJ; Lim YP
    Proteomics; 2007 Jul; 7(14):2384-97. PubMed ID: 17570516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry analysis of phosphotyrosine-containing proteins.
    Li J; Zhan X
    Mass Spectrom Rev; 2024; 43(4):857-887. PubMed ID: 36789499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway.
    Steen H; Kuster B; Fernandez M; Pandey A; Mann M
    J Biol Chem; 2002 Jan; 277(2):1031-9. PubMed ID: 11687594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Step SH2 Superbinder-Based Approach for Sensitive Analysis of Tyrosine Phosphoproteome.
    Yao Y; Wang Y; Wang S; Liu X; Liu Z; Li Y; Fang Z; Mao J; Zheng Y; Ye M
    J Proteome Res; 2019 Apr; 18(4):1870-1879. PubMed ID: 30875230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity-engineered protein scaffold for systematically exploring native phosphotyrosine signaling complexes in tumor samples.
    Chu B; He A; Tian Y; He W; Chen P; Hu J; Xu R; Zhou W; Zhang M; Yang P; Li SSC; Sun Y; Li P; Hunter T; Tian R
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8863-E8872. PubMed ID: 30190427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-Scale Phosphoproteomics Reveals Shp-2 Phosphatase-Dependent Regulators of Pdgf Receptor Signaling.
    Batth TS; Papetti M; Pfeiffer A; Tollenaere MAX; Francavilla C; Olsen JV
    Cell Rep; 2018 Mar; 22(10):2784-2796. PubMed ID: 29514104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoproteomics-based modeling defines the regulatory mechanism underlying aberrant EGFR signaling.
    Tasaki S; Nagasaki M; Kozuka-Hata H; Semba K; Gotoh N; Hattori S; Inoue J; Yamamoto T; Miyano S; Sugano S; Oyama M
    PLoS One; 2010 Nov; 5(11):e13926. PubMed ID: 21085658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAIMS and Phosphoproteomics of Fibroblast Growth Factor Signaling: Enhanced Identification of Multiply Phosphorylated Peptides.
    Zhao H; Cunningham DL; Creese AJ; Heath JK; Cooper HJ
    J Proteome Res; 2015 Dec; 14(12):5077-87. PubMed ID: 26503514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics.
    Blagoev B; Ong SE; Kratchmarova I; Mann M
    Nat Biotechnol; 2004 Sep; 22(9):1139-45. PubMed ID: 15314609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder.
    Bian Y; Li L; Dong M; Liu X; Kaneko T; Cheng K; Liu H; Voss C; Cao X; Wang Y; Litchfield D; Ye M; Li SS; Zou H
    Nat Chem Biol; 2016 Nov; 12(11):959-966. PubMed ID: 27642862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated Enrichment of Phosphotyrosine Peptides for High-Throughput Proteomics.
    Chang A; Leutert M; Rodriguez-Mias RA; Villén J
    J Proteome Res; 2023 Jun; 22(6):1868-1880. PubMed ID: 37097255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying oncogenic phosphotyrosine signaling networks through systems biology.
    Del Rosario AM; White FM
    Curr Opin Genet Dev; 2010 Feb; 20(1):23-30. PubMed ID: 20074929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection.
    Labots M; van der Mijn JC; Beekhof R; Piersma SR; de Goeij-de Haas RR; Pham TV; Knol JC; Dekker H; van Grieken NCT; Verheul HMW; Jiménez CR
    J Proteomics; 2017 Jun; 162():99-107. PubMed ID: 28442448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.